Home / News / India News / Article /
‘No severe illness yet from prevalent variant’
Updated On: 11 July, 2022 08:36 AM IST | New Delhi | Agencies
The Genomics Consortium says novel Coronavirus’s Omicron sub-variant BA.2.38 has not led to any increase in hospitalisation or disease severity
Listen to this article :
A medic collects a nasal swab sample of a man for COVID-19 test, in Jammu on Sunday. Pic/ANI
Omicron sub-variant BA.2’s offspring BA.2.38 has not led to any increase in hospitalisation or disease severity, and a few deaths reported recently are due to comorbidities, INSACOG said in its June 20 bulletin released on Sunday.
In the bulletin, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said many BA.2 cases have been reclassified to BA.2.38, which seems to be the prevalent sub-lineage in the latest sequencing batches, it said.
Read Next Story
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT